P-Smed ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.8% 20.9% 14.2% 21.7% 5.8%  
Credit score (0-100)  12 4 15 3 40  
Credit rating  BB B BB B BBB  
Credit limit (kDKK)  -0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -35.2 -39.2 304 -15.6 446  
EBITDA  -35.2 -39.2 20.8 -15.6 157  
EBIT  -35.2 -39.2 20.8 -15.6 157  
Pre-tax profit (PTP)  -35.3 -49.9 15.2 677.1 155.6  
Net earnings  -35.3 -49.9 15.2 545.2 123.2  
Pre-tax profit without non-rec. items  -35.3 -49.9 15.2 677 156  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 276  
Shareholders equity total  -42.9 -52.9 -37.6 508 631  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 10.6  
Balance sheet total (assets)  1,960 1,947 1,991 639 807  

Net Debt  -114 -150 -762 -639 -441  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -35.2 -39.2 304 -15.6 446  
Gross profit growth  -1,308.6% -11.4% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 -282.7 0.0 -288.1  
Balance sheet total (assets)  1,960 1,947 1,991 639 807  
Balance sheet change%  -1.6% -0.6% 2.3% -67.9% 26.2%  
Added value  -35.2 -39.2 303.5 -15.6 445.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 276  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 1.0 -1.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 6.8% 100.0% 35.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -1.8% -2.0% 1.0% 141.2% 21.8%  
ROI %  0.0% 0.0% 0.0% 742.5% 27.4%  
ROE %  -1.8% -2.6% 0.8% 43.6% 21.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -2.1% -2.6% -1.9% 79.4% 78.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  324.4% 383.7% -3,671.6% 4,089.1% -279.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 1.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 35.6%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  783.8 0.0 68.7 4.8 3.5  
Current Ratio  783.8 0.0 68.7 4.8 3.7  
Cash and cash equivalent  114.2 150.5 762.5 639.4 451.1  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,957.1 1,947.1 1,962.4 507.6 387.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0